nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—PPARG—hindlimb—muscle cancer	0.0456	0.207	CbGeAlD
Glipizide—PPARG—Teniposide—Etoposide—muscle cancer	0.0427	1	CbGdCrCtD
Glipizide—PPARG—appendage—muscle cancer	0.0392	0.177	CbGeAlD
Glipizide—Gliclazide—VEGFA—muscle cancer	0.0359	1	CrCbGaD
Glipizide—Eruption—Dactinomycin—muscle cancer	0.0179	0.0255	CcSEcCtD
Glipizide—Inappropriate antidiuretic hormone secretion—Vincristine—muscle cancer	0.0169	0.0241	CcSEcCtD
Glipizide—ABCC8—smooth muscle tissue—muscle cancer	0.0134	0.0606	CbGeAlD
Glipizide—PPARG—embryo—muscle cancer	0.013	0.0588	CbGeAlD
Glipizide—ABCC8—renal system—muscle cancer	0.0129	0.0583	CbGeAlD
Glipizide—KCNJ11—tendon—muscle cancer	0.0109	0.0494	CbGeAlD
Glipizide—Aplastic anaemia—Dactinomycin—muscle cancer	0.0103	0.0147	CcSEcCtD
Glipizide—Haematochezia—Doxorubicin—muscle cancer	0.0102	0.0146	CcSEcCtD
Glipizide—PPARG—smooth muscle tissue—muscle cancer	0.0102	0.0463	CbGeAlD
Glipizide—Gait disturbance—Vincristine—muscle cancer	0.0101	0.0144	CcSEcCtD
Glipizide—PPARG—renal system—muscle cancer	0.00984	0.0445	CbGeAlD
Glipizide—KCNJ11—head—muscle cancer	0.00937	0.0424	CbGeAlD
Glipizide—Urine output increased—Vincristine—muscle cancer	0.00887	0.0127	CcSEcCtD
Glipizide—ABCC8—head—muscle cancer	0.00863	0.039	CbGeAlD
Glipizide—ABCC8—testis—muscle cancer	0.00833	0.0377	CbGeAlD
Glipizide—Polyuria—Vincristine—muscle cancer	0.00811	0.0116	CcSEcCtD
Glipizide—Eruption—Methotrexate—muscle cancer	0.00774	0.0111	CcSEcCtD
Glipizide—PPARG—tendon—muscle cancer	0.00768	0.0348	CbGeAlD
Glipizide—PPARG—bone marrow—muscle cancer	0.00744	0.0337	CbGeAlD
Glipizide—Hyponatraemia—Vincristine—muscle cancer	0.00715	0.0102	CcSEcCtD
Glipizide—PPARG—vagina—muscle cancer	0.00713	0.0322	CbGeAlD
Glipizide—Liver disorder—Methotrexate—muscle cancer	0.00699	0.00997	CcSEcCtD
Glipizide—Eruption—Doxorubicin—muscle cancer	0.0067	0.00957	CcSEcCtD
Glipizide—PPARG—head—muscle cancer	0.00658	0.0298	CbGeAlD
Glipizide—Pancytopenia—Dactinomycin—muscle cancer	0.00654	0.00934	CcSEcCtD
Glipizide—PPARG—testis—muscle cancer	0.00636	0.0288	CbGeAlD
Glipizide—Pancytopenia—Vincristine—muscle cancer	0.00585	0.00835	CcSEcCtD
Glipizide—Dysuria—Vincristine—muscle cancer	0.00576	0.00822	CcSEcCtD
Glipizide—Agranulocytosis—Dactinomycin—muscle cancer	0.00573	0.00819	CcSEcCtD
Glipizide—Photosensitivity reaction—Vincristine—muscle cancer	0.00562	0.00802	CcSEcCtD
Glipizide—Hepatitis—Dactinomycin—muscle cancer	0.00552	0.00788	CcSEcCtD
Glipizide—Pharyngitis—Dactinomycin—muscle cancer	0.00547	0.00782	CcSEcCtD
Glipizide—Sweating—Vincristine—muscle cancer	0.00526	0.00751	CcSEcCtD
Glipizide—Flushing—Dactinomycin—muscle cancer	0.00512	0.00731	CcSEcCtD
Glipizide—Chills—Dactinomycin—muscle cancer	0.00495	0.00707	CcSEcCtD
Glipizide—Hypoaesthesia—Vincristine—muscle cancer	0.0049	0.007	CcSEcCtD
Glipizide—Liver injury—Doxorubicin—muscle cancer	0.0049	0.007	CcSEcCtD
Glipizide—Erythema—Dactinomycin—muscle cancer	0.0048	0.00686	CcSEcCtD
Glipizide—Pancytopenia—Etoposide—muscle cancer	0.00474	0.00676	CcSEcCtD
Glipizide—Jaundice cholestatic—Doxorubicin—muscle cancer	0.00469	0.0067	CcSEcCtD
Glipizide—Aplastic anaemia—Methotrexate—muscle cancer	0.00447	0.00638	CcSEcCtD
Glipizide—Ill-defined disorder—Dactinomycin—muscle cancer	0.00446	0.00636	CcSEcCtD
Glipizide—CYP3A4—renal system—muscle cancer	0.00439	0.0199	CbGeAlD
Glipizide—Jaundice—Etoposide—muscle cancer	0.00433	0.00619	CcSEcCtD
Glipizide—Malaise—Dactinomycin—muscle cancer	0.00433	0.00618	CcSEcCtD
Glipizide—Urine output increased—Methotrexate—muscle cancer	0.00431	0.00615	CcSEcCtD
Glipizide—Leukopenia—Dactinomycin—muscle cancer	0.0043	0.00614	CcSEcCtD
Glipizide—Gait disturbance—Doxorubicin—muscle cancer	0.00422	0.00603	CcSEcCtD
Glipizide—Hepatobiliary disease—Etoposide—muscle cancer	0.00421	0.006	CcSEcCtD
Glipizide—Agranulocytosis—Etoposide—muscle cancer	0.00415	0.00593	CcSEcCtD
Glipizide—Hepatocellular injury—Doxorubicin—muscle cancer	0.00412	0.00589	CcSEcCtD
Glipizide—Myalgia—Dactinomycin—muscle cancer	0.00409	0.00584	CcSEcCtD
Glipizide—Discomfort—Dactinomycin—muscle cancer	0.00404	0.00577	CcSEcCtD
Glipizide—Hypoaesthesia—Etoposide—muscle cancer	0.00397	0.00567	CcSEcCtD
Glipizide—Polyuria—Methotrexate—muscle cancer	0.00394	0.00562	CcSEcCtD
Glipizide—Oedema—Dactinomycin—muscle cancer	0.00392	0.00559	CcSEcCtD
Glipizide—Aplastic anaemia—Doxorubicin—muscle cancer	0.00387	0.00553	CcSEcCtD
Glipizide—Vertigo—Vincristine—muscle cancer	0.00385	0.0055	CcSEcCtD
Glipizide—Leukopenia—Vincristine—muscle cancer	0.00384	0.00548	CcSEcCtD
Glipizide—Thrombocytopenia—Dactinomycin—muscle cancer	0.00384	0.00548	CcSEcCtD
Glipizide—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00379	0.00541	CcSEcCtD
Glipizide—Anorexia—Dactinomycin—muscle cancer	0.00374	0.00533	CcSEcCtD
Glipizide—Eye disorder—Etoposide—muscle cancer	0.00373	0.00533	CcSEcCtD
Glipizide—Flushing—Etoposide—muscle cancer	0.0037	0.00529	CcSEcCtD
Glipizide—Hypertension—Vincristine—muscle cancer	0.0037	0.00529	CcSEcCtD
Glipizide—Myalgia—Vincristine—muscle cancer	0.00365	0.00521	CcSEcCtD
Glipizide—Visual disturbance—Methotrexate—muscle cancer	0.00365	0.00521	CcSEcCtD
Glipizide—Hypertonia—Doxorubicin—muscle cancer	0.00361	0.00516	CcSEcCtD
Glipizide—Abnormal vision—Doxorubicin—muscle cancer	0.0036	0.00513	CcSEcCtD
Glipizide—Chills—Etoposide—muscle cancer	0.00358	0.00511	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00357	0.0051	CcSEcCtD
Glipizide—Oedema—Vincristine—muscle cancer	0.0035	0.005	CcSEcCtD
Glipizide—Thrombocytopenia—Vincristine—muscle cancer	0.00343	0.00489	CcSEcCtD
Glipizide—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00342	0.00489	CcSEcCtD
Glipizide—Decreased appetite—Dactinomycin—muscle cancer	0.00341	0.00486	CcSEcCtD
Glipizide—Hyperhidrosis—Vincristine—muscle cancer	0.00338	0.00483	CcSEcCtD
Glipizide—Pain—Dactinomycin—muscle cancer	0.00335	0.00478	CcSEcCtD
Glipizide—Muscle spasms—Etoposide—muscle cancer	0.00334	0.00477	CcSEcCtD
Glipizide—Anorexia—Vincristine—muscle cancer	0.00334	0.00476	CcSEcCtD
Glipizide—Eczema—Doxorubicin—muscle cancer	0.00333	0.00476	CcSEcCtD
Glipizide—Feeling abnormal—Dactinomycin—muscle cancer	0.00323	0.00461	CcSEcCtD
Glipizide—Ill-defined disorder—Etoposide—muscle cancer	0.00322	0.0046	CcSEcCtD
Glipizide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0032	0.00458	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00319	0.00455	CcSEcCtD
Glipizide—Insomnia—Vincristine—muscle cancer	0.00317	0.00452	CcSEcCtD
Glipizide—Paraesthesia—Vincristine—muscle cancer	0.00314	0.00449	CcSEcCtD
Glipizide—Malaise—Etoposide—muscle cancer	0.00313	0.00447	CcSEcCtD
Glipizide—Vertigo—Etoposide—muscle cancer	0.00312	0.00446	CcSEcCtD
Glipizide—Leukopenia—Etoposide—muscle cancer	0.00311	0.00444	CcSEcCtD
Glipizide—Abdominal pain—Dactinomycin—muscle cancer	0.0031	0.00442	CcSEcCtD
Glipizide—Hypoglycaemia—Doxorubicin—muscle cancer	0.00307	0.00438	CcSEcCtD
Glipizide—Loss of consciousness—Etoposide—muscle cancer	0.00305	0.00436	CcSEcCtD
Glipizide—Decreased appetite—Vincristine—muscle cancer	0.00304	0.00435	CcSEcCtD
Glipizide—Gastrointestinal disorder—Vincristine—muscle cancer	0.00302	0.00432	CcSEcCtD
Glipizide—Hyponatraemia—Doxorubicin—muscle cancer	0.003	0.00429	CcSEcCtD
Glipizide—Hypertension—Etoposide—muscle cancer	0.003	0.00428	CcSEcCtD
Glipizide—Pain—Vincristine—muscle cancer	0.00299	0.00427	CcSEcCtD
Glipizide—Constipation—Vincristine—muscle cancer	0.00299	0.00427	CcSEcCtD
Glipizide—Diplopia—Doxorubicin—muscle cancer	0.00299	0.00427	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00299	0.00427	CcSEcCtD
Glipizide—Migraine—Doxorubicin—muscle cancer	0.00295	0.00421	CcSEcCtD
Glipizide—Discomfort—Etoposide—muscle cancer	0.00292	0.00417	CcSEcCtD
Glipizide—Hypersensitivity—Dactinomycin—muscle cancer	0.00289	0.00412	CcSEcCtD
Glipizide—Abdominal discomfort—Methotrexate—muscle cancer	0.00286	0.00409	CcSEcCtD
Glipizide—Gastrointestinal pain—Vincristine—muscle cancer	0.00286	0.00409	CcSEcCtD
Glipizide—Confusional state—Etoposide—muscle cancer	0.00286	0.00408	CcSEcCtD
Glipizide—Pancytopenia—Methotrexate—muscle cancer	0.00284	0.00405	CcSEcCtD
Glipizide—Asthenia—Dactinomycin—muscle cancer	0.00281	0.00401	CcSEcCtD
Glipizide—Dysuria—Methotrexate—muscle cancer	0.00279	0.00399	CcSEcCtD
Glipizide—Thrombocytopenia—Etoposide—muscle cancer	0.00278	0.00396	CcSEcCtD
Glipizide—Abdominal pain—Vincristine—muscle cancer	0.00277	0.00395	CcSEcCtD
Glipizide—Hyperhidrosis—Etoposide—muscle cancer	0.00274	0.00391	CcSEcCtD
Glipizide—Abdominal pain upper—Doxorubicin—muscle cancer	0.00273	0.0039	CcSEcCtD
Glipizide—Photosensitivity reaction—Methotrexate—muscle cancer	0.00273	0.00389	CcSEcCtD
Glipizide—Anorexia—Etoposide—muscle cancer	0.0027	0.00386	CcSEcCtD
Glipizide—Diarrhoea—Dactinomycin—muscle cancer	0.00268	0.00383	CcSEcCtD
Glipizide—Drowsiness—Methotrexate—muscle cancer	0.00266	0.0038	CcSEcCtD
Glipizide—Conjunctivitis—Methotrexate—muscle cancer	0.00259	0.0037	CcSEcCtD
Glipizide—Hypersensitivity—Vincristine—muscle cancer	0.00258	0.00368	CcSEcCtD
Glipizide—Sweating—Methotrexate—muscle cancer	0.00255	0.00365	CcSEcCtD
Glipizide—Paraesthesia—Etoposide—muscle cancer	0.00255	0.00364	CcSEcCtD
Glipizide—Dyspnoea—Etoposide—muscle cancer	0.00253	0.00361	CcSEcCtD
Glipizide—Somnolence—Etoposide—muscle cancer	0.00252	0.0036	CcSEcCtD
Glipizide—Hepatobiliary disease—Methotrexate—muscle cancer	0.00252	0.0036	CcSEcCtD
Glipizide—Asthenia—Vincristine—muscle cancer	0.00251	0.00359	CcSEcCtD
Glipizide—Vomiting—Dactinomycin—muscle cancer	0.00249	0.00356	CcSEcCtD
Glipizide—Agranulocytosis—Methotrexate—muscle cancer	0.00249	0.00355	CcSEcCtD
Glipizide—Rash—Dactinomycin—muscle cancer	0.00247	0.00353	CcSEcCtD
Glipizide—Decreased appetite—Etoposide—muscle cancer	0.00247	0.00352	CcSEcCtD
Glipizide—Pancytopenia—Doxorubicin—muscle cancer	0.00246	0.00351	CcSEcCtD
Glipizide—Gastrointestinal disorder—Etoposide—muscle cancer	0.00245	0.0035	CcSEcCtD
Glipizide—Constipation—Etoposide—muscle cancer	0.00243	0.00346	CcSEcCtD
Glipizide—Pain—Etoposide—muscle cancer	0.00243	0.00346	CcSEcCtD
Glipizide—Dysuria—Doxorubicin—muscle cancer	0.00242	0.00345	CcSEcCtD
Glipizide—Diarrhoea—Vincristine—muscle cancer	0.0024	0.00342	CcSEcCtD
Glipizide—Hepatitis—Methotrexate—muscle cancer	0.00239	0.00341	CcSEcCtD
Glipizide—Pharyngitis—Methotrexate—muscle cancer	0.00237	0.00339	CcSEcCtD
Glipizide—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00236	0.00337	CcSEcCtD
Glipizide—Feeling abnormal—Etoposide—muscle cancer	0.00234	0.00334	CcSEcCtD
Glipizide—Nausea—Dactinomycin—muscle cancer	0.00233	0.00332	CcSEcCtD
Glipizide—Gastrointestinal pain—Etoposide—muscle cancer	0.00232	0.00331	CcSEcCtD
Glipizide—Dizziness—Vincristine—muscle cancer	0.00232	0.00331	CcSEcCtD
Glipizide—Drowsiness—Doxorubicin—muscle cancer	0.00231	0.00329	CcSEcCtD
Glipizide—Visual impairment—Methotrexate—muscle cancer	0.0023	0.00329	CcSEcCtD
Glipizide—Urticaria—Etoposide—muscle cancer	0.00225	0.00322	CcSEcCtD
Glipizide—Jaundice—Doxorubicin—muscle cancer	0.00225	0.00321	CcSEcCtD
Glipizide—Abdominal pain—Etoposide—muscle cancer	0.00224	0.0032	CcSEcCtD
Glipizide—Conjunctivitis—Doxorubicin—muscle cancer	0.00224	0.0032	CcSEcCtD
Glipizide—Eye disorder—Methotrexate—muscle cancer	0.00223	0.00319	CcSEcCtD
Glipizide—Vomiting—Vincristine—muscle cancer	0.00223	0.00318	CcSEcCtD
Glipizide—Sweating—Doxorubicin—muscle cancer	0.00221	0.00316	CcSEcCtD
Glipizide—Rash—Vincristine—muscle cancer	0.00221	0.00315	CcSEcCtD
Glipizide—Dermatitis—Vincristine—muscle cancer	0.00221	0.00315	CcSEcCtD
Glipizide—Headache—Vincristine—muscle cancer	0.00219	0.00313	CcSEcCtD
Glipizide—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00218	0.00311	CcSEcCtD
Glipizide—Agranulocytosis—Doxorubicin—muscle cancer	0.00215	0.00307	CcSEcCtD
Glipizide—Chills—Methotrexate—muscle cancer	0.00215	0.00306	CcSEcCtD
Glipizide—Hypersensitivity—Etoposide—muscle cancer	0.00209	0.00298	CcSEcCtD
Glipizide—Erythema—Methotrexate—muscle cancer	0.00208	0.00297	CcSEcCtD
Glipizide—Nausea—Vincristine—muscle cancer	0.00208	0.00297	CcSEcCtD
Glipizide—Rhinitis—Doxorubicin—muscle cancer	0.00208	0.00296	CcSEcCtD
Glipizide—Hepatitis—Doxorubicin—muscle cancer	0.00207	0.00296	CcSEcCtD
Glipizide—Hypoaesthesia—Doxorubicin—muscle cancer	0.00206	0.00294	CcSEcCtD
Glipizide—Pharyngitis—Doxorubicin—muscle cancer	0.00205	0.00293	CcSEcCtD
Glipizide—Asthenia—Etoposide—muscle cancer	0.00203	0.00291	CcSEcCtD
Glipizide—Pruritus—Etoposide—muscle cancer	0.00201	0.00286	CcSEcCtD
Glipizide—Visual impairment—Doxorubicin—muscle cancer	0.002	0.00285	CcSEcCtD
Glipizide—Vision blurred—Methotrexate—muscle cancer	0.00196	0.0028	CcSEcCtD
Glipizide—Diarrhoea—Etoposide—muscle cancer	0.00194	0.00277	CcSEcCtD
Glipizide—Eye disorder—Doxorubicin—muscle cancer	0.00193	0.00276	CcSEcCtD
Glipizide—Ill-defined disorder—Methotrexate—muscle cancer	0.00193	0.00276	CcSEcCtD
Glipizide—Flushing—Doxorubicin—muscle cancer	0.00192	0.00274	CcSEcCtD
Glipizide—Malaise—Methotrexate—muscle cancer	0.00188	0.00268	CcSEcCtD
Glipizide—Dizziness—Etoposide—muscle cancer	0.00188	0.00268	CcSEcCtD
Glipizide—Vertigo—Methotrexate—muscle cancer	0.00187	0.00267	CcSEcCtD
Glipizide—Leukopenia—Methotrexate—muscle cancer	0.00186	0.00266	CcSEcCtD
Glipizide—Chills—Doxorubicin—muscle cancer	0.00186	0.00265	CcSEcCtD
Glipizide—Arrhythmia—Doxorubicin—muscle cancer	0.00185	0.00264	CcSEcCtD
Glipizide—Vomiting—Etoposide—muscle cancer	0.0018	0.00257	CcSEcCtD
Glipizide—Erythema—Doxorubicin—muscle cancer	0.0018	0.00257	CcSEcCtD
Glipizide—Rash—Etoposide—muscle cancer	0.00179	0.00255	CcSEcCtD
Glipizide—Dermatitis—Etoposide—muscle cancer	0.00179	0.00255	CcSEcCtD
Glipizide—Headache—Etoposide—muscle cancer	0.00178	0.00254	CcSEcCtD
Glipizide—Flatulence—Doxorubicin—muscle cancer	0.00178	0.00254	CcSEcCtD
Glipizide—Myalgia—Methotrexate—muscle cancer	0.00177	0.00253	CcSEcCtD
Glipizide—Arthralgia—Methotrexate—muscle cancer	0.00177	0.00253	CcSEcCtD
Glipizide—Tension—Doxorubicin—muscle cancer	0.00177	0.00253	CcSEcCtD
Glipizide—Discomfort—Methotrexate—muscle cancer	0.00175	0.0025	CcSEcCtD
Glipizide—Nervousness—Doxorubicin—muscle cancer	0.00175	0.0025	CcSEcCtD
Glipizide—Muscle spasms—Doxorubicin—muscle cancer	0.00173	0.00247	CcSEcCtD
Glipizide—Confusional state—Methotrexate—muscle cancer	0.00171	0.00245	CcSEcCtD
Glipizide—Vision blurred—Doxorubicin—muscle cancer	0.0017	0.00243	CcSEcCtD
Glipizide—Nausea—Etoposide—muscle cancer	0.00168	0.00241	CcSEcCtD
Glipizide—Ill-defined disorder—Doxorubicin—muscle cancer	0.00167	0.00239	CcSEcCtD
Glipizide—Thrombocytopenia—Methotrexate—muscle cancer	0.00166	0.00237	CcSEcCtD
Glipizide—Hyperhidrosis—Methotrexate—muscle cancer	0.00164	0.00234	CcSEcCtD
Glipizide—Malaise—Doxorubicin—muscle cancer	0.00163	0.00232	CcSEcCtD
Glipizide—Vertigo—Doxorubicin—muscle cancer	0.00162	0.00231	CcSEcCtD
Glipizide—Anorexia—Methotrexate—muscle cancer	0.00162	0.00231	CcSEcCtD
Glipizide—Syncope—Doxorubicin—muscle cancer	0.00162	0.00231	CcSEcCtD
Glipizide—Leukopenia—Doxorubicin—muscle cancer	0.00161	0.0023	CcSEcCtD
Glipizide—Loss of consciousness—Doxorubicin—muscle cancer	0.00158	0.00226	CcSEcCtD
Glipizide—Hypertension—Doxorubicin—muscle cancer	0.00156	0.00222	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00155	0.00221	CcSEcCtD
Glipizide—Insomnia—Methotrexate—muscle cancer	0.00154	0.00219	CcSEcCtD
Glipizide—Myalgia—Doxorubicin—muscle cancer	0.00153	0.00219	CcSEcCtD
Glipizide—Arthralgia—Doxorubicin—muscle cancer	0.00153	0.00219	CcSEcCtD
Glipizide—Anxiety—Doxorubicin—muscle cancer	0.00153	0.00218	CcSEcCtD
Glipizide—Paraesthesia—Methotrexate—muscle cancer	0.00153	0.00218	CcSEcCtD
Glipizide—Discomfort—Doxorubicin—muscle cancer	0.00152	0.00216	CcSEcCtD
Glipizide—Dyspnoea—Methotrexate—muscle cancer	0.00151	0.00216	CcSEcCtD
Glipizide—Somnolence—Methotrexate—muscle cancer	0.00151	0.00216	CcSEcCtD
Glipizide—Dyspepsia—Methotrexate—muscle cancer	0.0015	0.00214	CcSEcCtD
Glipizide—Confusional state—Doxorubicin—muscle cancer	0.00148	0.00212	CcSEcCtD
Glipizide—Decreased appetite—Methotrexate—muscle cancer	0.00148	0.00211	CcSEcCtD
Glipizide—Oedema—Doxorubicin—muscle cancer	0.00147	0.0021	CcSEcCtD
Glipizide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00147	0.00209	CcSEcCtD
Glipizide—Pain—Methotrexate—muscle cancer	0.00145	0.00207	CcSEcCtD
Glipizide—Shock—Doxorubicin—muscle cancer	0.00145	0.00207	CcSEcCtD
Glipizide—Thrombocytopenia—Doxorubicin—muscle cancer	0.00144	0.00206	CcSEcCtD
Glipizide—Hyperhidrosis—Doxorubicin—muscle cancer	0.00142	0.00203	CcSEcCtD
Glipizide—Anorexia—Doxorubicin—muscle cancer	0.0014	0.002	CcSEcCtD
Glipizide—Feeling abnormal—Methotrexate—muscle cancer	0.0014	0.002	CcSEcCtD
Glipizide—Gastrointestinal pain—Methotrexate—muscle cancer	0.00139	0.00198	CcSEcCtD
Glipizide—Urticaria—Methotrexate—muscle cancer	0.00135	0.00193	CcSEcCtD
Glipizide—Abdominal pain—Methotrexate—muscle cancer	0.00134	0.00192	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00134	0.00191	CcSEcCtD
Glipizide—Insomnia—Doxorubicin—muscle cancer	0.00133	0.0019	CcSEcCtD
Glipizide—Paraesthesia—Doxorubicin—muscle cancer	0.00132	0.00189	CcSEcCtD
Glipizide—Dyspnoea—Doxorubicin—muscle cancer	0.00131	0.00187	CcSEcCtD
Glipizide—Somnolence—Doxorubicin—muscle cancer	0.00131	0.00187	CcSEcCtD
Glipizide—Dyspepsia—Doxorubicin—muscle cancer	0.00129	0.00185	CcSEcCtD
Glipizide—Decreased appetite—Doxorubicin—muscle cancer	0.00128	0.00183	CcSEcCtD
Glipizide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00127	0.00181	CcSEcCtD
Glipizide—Pain—Doxorubicin—muscle cancer	0.00126	0.0018	CcSEcCtD
Glipizide—Constipation—Doxorubicin—muscle cancer	0.00126	0.0018	CcSEcCtD
Glipizide—Hypersensitivity—Methotrexate—muscle cancer	0.00125	0.00179	CcSEcCtD
Glipizide—Asthenia—Methotrexate—muscle cancer	0.00122	0.00174	CcSEcCtD
Glipizide—Feeling abnormal—Doxorubicin—muscle cancer	0.00121	0.00173	CcSEcCtD
Glipizide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.0012	0.00172	CcSEcCtD
Glipizide—Pruritus—Methotrexate—muscle cancer	0.0012	0.00172	CcSEcCtD
Glipizide—Urticaria—Doxorubicin—muscle cancer	0.00117	0.00167	CcSEcCtD
Glipizide—Abdominal pain—Doxorubicin—muscle cancer	0.00116	0.00166	CcSEcCtD
Glipizide—Diarrhoea—Methotrexate—muscle cancer	0.00116	0.00166	CcSEcCtD
Glipizide—Dizziness—Methotrexate—muscle cancer	0.00112	0.0016	CcSEcCtD
Glipizide—Hypersensitivity—Doxorubicin—muscle cancer	0.00108	0.00155	CcSEcCtD
Glipizide—Vomiting—Methotrexate—muscle cancer	0.00108	0.00154	CcSEcCtD
Glipizide—Rash—Methotrexate—muscle cancer	0.00107	0.00153	CcSEcCtD
Glipizide—Dermatitis—Methotrexate—muscle cancer	0.00107	0.00153	CcSEcCtD
Glipizide—Headache—Methotrexate—muscle cancer	0.00106	0.00152	CcSEcCtD
Glipizide—Asthenia—Doxorubicin—muscle cancer	0.00106	0.00151	CcSEcCtD
Glipizide—Pruritus—Doxorubicin—muscle cancer	0.00104	0.00149	CcSEcCtD
Glipizide—Nausea—Methotrexate—muscle cancer	0.00101	0.00144	CcSEcCtD
Glipizide—Diarrhoea—Doxorubicin—muscle cancer	0.00101	0.00144	CcSEcCtD
Glipizide—Dizziness—Doxorubicin—muscle cancer	0.000973	0.00139	CcSEcCtD
Glipizide—Vomiting—Doxorubicin—muscle cancer	0.000935	0.00134	CcSEcCtD
Glipizide—Rash—Doxorubicin—muscle cancer	0.000927	0.00132	CcSEcCtD
Glipizide—Dermatitis—Doxorubicin—muscle cancer	0.000927	0.00132	CcSEcCtD
Glipizide—Headache—Doxorubicin—muscle cancer	0.000922	0.00132	CcSEcCtD
Glipizide—Nausea—Doxorubicin—muscle cancer	0.000874	0.00125	CcSEcCtD
